AAPL308.06+13.68 (+4.65%) ▲|ABBV260.28+9.22 (+3.67%) ▲|ABT95.23+3.05 (+3.31%) ▲|ACN137.34+6.21 (+4.74%) ▲|ADBE219.67+8.69 (+4.12%) ▲|AMAT596.44-54.48 (-8.37%) ▼|AMD513.02-27.87 (-5.15%) ▼|AMGN373.03+11.70 (+3.24%) ▲|AMT165.72-0.36 (-0.22%) ▼|AMZN243.42+1.72 (+0.71%) ▲|AVGO360.59-8.76 (-2.37%) ▼|AXP351.20+4.15 (+1.20%) ▲|BA225.98+7.40 (+3.38%) ▲|BAC58.62+0.26 (+0.45%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK992.05+11.67 (+1.19%) ▲|BMY57.97+2.16 (+3.87%) ▲|BNY146.19+0.17 (+0.12%) ▲|BRK-B506.38+6.64 (+1.33%) ▲|C139.65-0.48 (-0.34%) ▼|CAT963.39-28.02 (-2.83%) ▼|CL95.20+2.44 (+2.63%) ▲|CMCSA23.75+0.02 (+0.06%) ▲|COF204.38-0.44 (-0.21%) ▼|COP104.26+1.04 (+1.01%) ▲|COST951.40+26.73 (+2.89%) ▲|CRM165.36+2.13 (+1.30%) ▲|CSCO112.72-4.29 (-3.67%) ▼|CVS104.70-0.12 (-0.11%) ▼|CVX168.74+3.05 (+1.84%) ▲|DE620.75-6.88 (-1.10%) ▼|DHR197.24+3.52 (+1.82%) ▲|DIS99.28+3.57 (+3.73%) ▲|DUK129.46+3.69 (+2.93%) ▲|EMR138.93-0.60 (-0.43%) ▼|FDX313.07-0.82 (-0.26%) ▼|GD372.16+10.89 (+3.01%) ▲|GE376.93+1.99 (+0.53%) ▲|GEV1,109.39-24.96 (-2.20%) ▼|GILD131.18+5.21 (+4.14%) ▲|GM75.74+0.22 (+0.29%) ▲|GOOG356.40-1.49 (-0.42%) ▼|GOOGL360.23-0.98 (-0.27%) ▼|GS1,020.83+1.22 (+0.12%) ▲|HD357.29+6.45 (+1.84%) ▲|HON229.59+7.84 (+3.54%) ▲|IBM288.58+2.33 (+0.81%) ▲|INTC119.07-7.95 (-6.26%) ▼|INTU274.74+7.66 (+2.87%) ▲|ISRG425.32+22.94 (+5.70%) ▲|JNJ261.96+7.98 (+3.14%) ▲|JPM333.40-0.68 (-0.20%) ▼|KO83.75+2.46 (+3.02%) ▲|LIN545.51+11.96 (+2.24%) ▲|LLY1,203.65+11.91 (+1.00%) ▲|LMT544.69+22.87 (+4.38%) ▲|LOW226.79+4.87 (+2.19%) ▲|LRCX348.45-42.82 (-10.94%) ▼|MA538.21+15.77 (+3.02%) ▲|MCD280.20+10.77 (+4.00%) ▲|MDLZ60.92+1.57 (+2.65%) ▲|MDT83.16+3.96 (+5.00%) ▲|META584.25-28.66 (-4.68%) ▼|MMM160.71+0.75 (+0.47%) ▲|MO72.64+1.10 (+1.54%) ▲|MRK128.98+3.61 (+2.88%) ▲|MS214.00+2.14 (+1.01%) ▲|MSFT390.56+6.28 (+1.63%) ▲|MU963.56-68.72 (-6.66%) ▼|NEE88.14+1.77 (+2.05%) ▲|NFLX77.79+3.60 (+4.85%) ▲|NKE44.05+0.99 (+2.30%) ▲|NOW105.65-0.15 (-0.14%) ▼|NVDA194.53-3.05 (-1.54%) ▼|ORCL140.17-2.34 (-1.64%) ▼|PEP144.21+3.05 (+2.16%) ▲|PFE24.31+0.43 (+1.78%) ▲|PG150.88+3.45 (+2.34%) ▲|PLTR129.85+4.12 (+3.28%) ▲|PM182.64+4.95 (+2.79%) ▲|QCOM175.15-6.77 (-3.72%) ▼|RTX199.15+7.37 (+3.84%) ▲|SBUX104.31+0.92 (+0.89%) ▲|SCHW96.96+1.18 (+1.23%) ▲|SO97.81+2.69 (+2.83%) ▲|SPG225.49+2.49 (+1.11%) ▲|T20.55+0.07 (+0.34%) ▲|TMO520.99+7.66 (+1.49%) ▲|TMUS177.55+4.49 (+2.59%) ▲|TSLA392.94-32.36 (-7.61%) ▼|TXN291.69-6.72 (-2.25%) ▼|UBER74.40+1.74 (+2.39%) ▲|UNH423.95-2.60 (-0.61%) ▼|UNP281.85+4.12 (+1.48%) ▲|UPS110.39+0.85 (+0.78%) ▲|USB61.56-0.40 (-0.65%) ▼|V360.35+9.27 (+2.64%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.49-0.45 (-0.52%) ▼|WMT112.01+3.19 (+2.93%) ▲|XOM136.75+0.47 (+0.34%) ▲|AAPL308.06+13.68 (+4.65%) ▲|ABBV260.28+9.22 (+3.67%) ▲|ABT95.23+3.05 (+3.31%) ▲|ACN137.34+6.21 (+4.74%) ▲|ADBE219.67+8.69 (+4.12%) ▲|AMAT596.44-54.48 (-8.37%) ▼|AMD513.02-27.87 (-5.15%) ▼|AMGN373.03+11.70 (+3.24%) ▲|AMT165.72-0.36 (-0.22%) ▼|AMZN243.42+1.72 (+0.71%) ▲|AVGO360.59-8.76 (-2.37%) ▼|AXP351.20+4.15 (+1.20%) ▲|BA225.98+7.40 (+3.38%) ▲|BAC58.62+0.26 (+0.45%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK992.05+11.67 (+1.19%) ▲|BMY57.97+2.16 (+3.87%) ▲|BNY146.19+0.17 (+0.12%) ▲|BRK-B506.38+6.64 (+1.33%) ▲|C139.65-0.48 (-0.34%) ▼|CAT963.39-28.02 (-2.83%) ▼|CL95.20+2.44 (+2.63%) ▲|CMCSA23.75+0.02 (+0.06%) ▲|COF204.38-0.44 (-0.21%) ▼|COP104.26+1.04 (+1.01%) ▲|COST951.40+26.73 (+2.89%) ▲|CRM165.36+2.13 (+1.30%) ▲|CSCO112.72-4.29 (-3.67%) ▼|CVS104.70-0.12 (-0.11%) ▼|CVX168.74+3.05 (+1.84%) ▲|DE620.75-6.88 (-1.10%) ▼|DHR197.24+3.52 (+1.82%) ▲|DIS99.28+3.57 (+3.73%) ▲|DUK129.46+3.69 (+2.93%) ▲|EMR138.93-0.60 (-0.43%) ▼|FDX313.07-0.82 (-0.26%) ▼|GD372.16+10.89 (+3.01%) ▲|GE376.93+1.99 (+0.53%) ▲|GEV1,109.39-24.96 (-2.20%) ▼|GILD131.18+5.21 (+4.14%) ▲|GM75.74+0.22 (+0.29%) ▲|GOOG356.40-1.49 (-0.42%) ▼|GOOGL360.23-0.98 (-0.27%) ▼|GS1,020.83+1.22 (+0.12%) ▲|HD357.29+6.45 (+1.84%) ▲|HON229.59+7.84 (+3.54%) ▲|IBM288.58+2.33 (+0.81%) ▲|INTC119.07-7.95 (-6.26%) ▼|INTU274.74+7.66 (+2.87%) ▲|ISRG425.32+22.94 (+5.70%) ▲|JNJ261.96+7.98 (+3.14%) ▲|JPM333.40-0.68 (-0.20%) ▼|KO83.75+2.46 (+3.02%) ▲|LIN545.51+11.96 (+2.24%) ▲|LLY1,203.65+11.91 (+1.00%) ▲|LMT544.69+22.87 (+4.38%) ▲|LOW226.79+4.87 (+2.19%) ▲|LRCX348.45-42.82 (-10.94%) ▼|MA538.21+15.77 (+3.02%) ▲|MCD280.20+10.77 (+4.00%) ▲|MDLZ60.92+1.57 (+2.65%) ▲|MDT83.16+3.96 (+5.00%) ▲|META584.25-28.66 (-4.68%) ▼|MMM160.71+0.75 (+0.47%) ▲|MO72.64+1.10 (+1.54%) ▲|MRK128.98+3.61 (+2.88%) ▲|MS214.00+2.14 (+1.01%) ▲|MSFT390.56+6.28 (+1.63%) ▲|MU963.56-68.72 (-6.66%) ▼|NEE88.14+1.77 (+2.05%) ▲|NFLX77.79+3.60 (+4.85%) ▲|NKE44.05+0.99 (+2.30%) ▲|NOW105.65-0.15 (-0.14%) ▼|NVDA194.53-3.05 (-1.54%) ▼|ORCL140.17-2.34 (-1.64%) ▼|PEP144.21+3.05 (+2.16%) ▲|PFE24.31+0.43 (+1.78%) ▲|PG150.88+3.45 (+2.34%) ▲|PLTR129.85+4.12 (+3.28%) ▲|PM182.64+4.95 (+2.79%) ▲|QCOM175.15-6.77 (-3.72%) ▼|RTX199.15+7.37 (+3.84%) ▲|SBUX104.31+0.92 (+0.89%) ▲|SCHW96.96+1.18 (+1.23%) ▲|SO97.81+2.69 (+2.83%) ▲|SPG225.49+2.49 (+1.11%) ▲|T20.55+0.07 (+0.34%) ▲|TMO520.99+7.66 (+1.49%) ▲|TMUS177.55+4.49 (+2.59%) ▲|TSLA392.94-32.36 (-7.61%) ▼|TXN291.69-6.72 (-2.25%) ▼|UBER74.40+1.74 (+2.39%) ▲|UNH423.95-2.60 (-0.61%) ▼|UNP281.85+4.12 (+1.48%) ▲|UPS110.39+0.85 (+0.78%) ▲|USB61.56-0.40 (-0.65%) ▼|V360.35+9.27 (+2.64%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.49-0.45 (-0.52%) ▼|WMT112.01+3.19 (+2.93%) ▲|XOM136.75+0.47 (+0.34%) ▲|
38.5 C
New York
Thursday, July 2, 2026

Tag: research

newssourceFORcompanyinformationcontent1releasesmarket

Human Microbiome Market to Grow at 25.6% CAGR Through 2030

"Rising Research and Innovation in Microbiome-Based Drugs and Diagnostics Drive New Frontiers in Disease Detection, Prevention and Treatment" 
"Rising Research and Innovation in Microbiome-Based Drugs and Diagnostics Drive New Frontiers in Disease Detection, Prevention and Treatment"

New Trail, New Moves: Sheridan College Just Got More Connected

BRAMPTON, ON, July 30, 2025 /CNW/ - Sheridan College is enhancing safety and accessibility of active transportation infrastructure on campus with the support of...

OneSchool Global Celebrates a Historic 2024-2025 North American School Year

OSG North America Congratulates Graduating Class Recognizes Seniors' Community Service, Donations, Research Accomplishments BRIDGEWATER, N.J., July 30, 2025 /PRNewswire/ -- OneSchool Global (OSG)—a global, tech-centric network of...

Seasats Autonomous Surface Vessel Crosses The Pacific, Completes 7,500+ Mile Mission

SAN DIEGO, July 30, 2025 /PRNewswire/ -- Seasats, a leader in autonomous maritime systems, announced today that one of the company's autonomous surface vessels...

Young, Certified, and Winners: Pearson’s Certiport Announces 2025 Microsoft Office Specialist World Champions

ORLANDO, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Pearson is proud to recognize the winners of the 2025 Microsoft Office Specialist (MOS) World Championship, announced by Certiport, a Pearson VUE business, and the leading provider of performance-based IT certification exams that accelerate academic and career opportunities for learners.

Quantiphi, Snowflake Accelerate Chalo’s AI-Driven Data Modernization for Public Transport Transformation

MARLBOROUGH, Mass., July 30, 2025 /PRNewswire/ -- Quantiphi, an AI-first digital engineering company and an Elite Tier partner of Snowflake, the AI Data Cloud...

Autism United of Wisconsin Welcomes All to Zoofari Stroll 2025: A Sensory Friendly and Family Fun Day for Kids, Teens, Adults, Families!

Register Now and Join Us on Sunday, August 24 at Milwaukee County Zoo to Help Raise Acceptance, Inclusion and Research Funding for All Impacted...

Iveco Group 2025 Second Quarter

The following is an extract from the “Iveco Group 2025 Second Quarter” press release. The complete press release can be accessed by visiting the media section of the Iveco Group corporate website: https://www.ivecogroup.com/media/corporate_press_releases or consulting the accompanying PDF:

Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision

WARREN, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the Company’s significant insider ownership of outstanding common stock, as most recently reported on July 10, 2025, on Form 8-K filed with the Securities and Exchange Commission.

Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis

– Nuvisertib (TP-3654), an oral investigational highly selective PIM-1 kinase inhibitor, is being evaluated in patients with relapsed or refractory myelofibrosis (MF) – MARLBOROUGH, Mass.,...

Construction Leaders Facing Urgent Risks from Policy Shifts and Rising Costs, Warns Info-Tech Research Group in New Report

Ongoing trade policy shifts, rising costs, and persistent supply chain disruptions are causing delays, budget overruns, and growing contract disputes across the construction industry....

Construction Leaders Facing Urgent Risks from Policy Shifts and Rising Costs, Warns Info-Tech Research Group in New Report

Ongoing trade policy shifts, rising costs, and persistent supply chain disruptions are causing delays, budget overruns, and growing contract disputes across the construction industry....

Final results

FORESIGHT VENTURES VCT PLC
LEI: 213800R88MRC4Y3OIW86
29 July 2025

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-Aβ protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsResearch

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers